Gulf study tests which blood thinner best protects hearts
NCT ID NCT07572747
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two common blood thinners, aspirin and clopidogrel, to see which one better prevents heart attacks, strokes, and related events in people with stable heart disease. About 6,740 participants from Gulf countries will take one of the two drugs for several years. The goal is to find the most effective long-term prevention strategy.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Aspirin and clopidogrel
- What this could lead to
- If successful, this could show that clopidogrel is better than aspirin at preventing heart attacks and strokes in people with stable heart disease.
- What could go wrong
- This is a large phase 3 trial, but it hasn't started yet. Results may not apply to all patients, and both drugs carry bleeding risks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC CORONARY SYNDROME are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a higher dose of adenosine sharpen heart scans?
- Can a trained eye match ultrasound for heart stent placement?
- Could a quicker, cheaper scan replace the gold standard for heart blood flow?
- Could a neck ultrasound replace heart CT scans for chest pain patients?
- Fish oil derivative may calm heart inflammation and stabilize plaques
- Heart stent mystery: new diagnostic strategy could reveal hidden causes of Post-PCI angina